Drug Database · Clinicians

Dolutegravir + Lamivudine + Tenofovir disoproxil

Brands (3) Acriptega, Kovatraxx, TeldyShow all

Antiviral combination; Direct acting antiviral; and others PH FDA category
Fixed-dose combination.

Rx · Prescription drug7 PH products
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: TIVICAY and TIVICAY PD are indicated in combination with other antiretroviral agents for the treatment of HIV ‑ 1 infection in adults (treatment-naïve or -experienced) and in pediatric patients (treatment-naïve or… US FDA label

  • Use: EPIVIR is a nucleoside analogue indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV‑1) infection. US FDA label

  • Use: in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older weighing at least 10 kg. US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Film-coated tablet: 50 mg/300 mg/300 mg, 300 mg/300 mg/50 mg

Registered products in the Philippines

7 products registered with the Food and Drug Administration (FDA) Philippines list Dolutegravir + Lamivudine + Tenofovir disoproxil as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products7
Philippine FDA-registered products for Dolutegravir + Lamivudine + Tenofovir disoproxil
Package insert
AcriptegaLamivudine + Tenofovir disoproxil Fumarate + Dolutegravir (as sodium)
300 mg/300 mg/50 mg Film-Coated TabletBlue colored HDPE Plastic Bottle with blue opaque Polypropylene Cap with silica gel (as dessicant) (Box of 1 bottle x 30 tablets)
Rx
Mylan Laboratories LimitedIndia
Importer: Faberco Life Sciences Inc.
DR-XY48284
Aug 15, 2027
KovatraxxDolutegravir + Lamivudine + Tenofovir Disoproxil Fumarate
50 mg/300 mg/ 300 mg Film-Coated Tablet100 cc round white HDPE with continuous thread closure x 30's (box of 30's) 120 cc round white HDPE with continuous thread closure x 30's (box of 30's) 250 cc round white HDPE with continuous thread closure x 90's (box of 90's) 250 cc round white HDPE with continuous thread closure x 100's (box of 100's) 400 ce round white HDPE with continuous thread closure x 180's (box of 180's)
Rx
Macleods Pharmaceuticals LimitedIndia
Macleods Pharmaceuticals Philippines, Inc.
DR-XY49561
Oct 20, 2030
NoneDolutegravir (as sodium) + Lamivudine + Tenofovir disoproxil fumarate
50 mg/300 mg/300 mg Film-Coated Tablet100 cc white opaque HDPE bottle (with a 38 mm neck and child-resistant plastic cap with pulp liner) x 30’s (Box of 30’s)
Rx
Hetero Labs LimitedIndia
Camber Pharmaceuticals, Inc.
DR-XY48002
Aug 11, 2031
TeldyDolutegravir (as sodium) + Lamivudine + Tenofovir disoproxil fumarate
50 mg/300 mg/300 mg Film Coated TabletWhite opaque HDPE bottle with child-resistant PP cap ottle of 30 tablets in individual box)
Rx
Hetero Labs LimitedIndia
Camber Pharmaceuticals, Inc.
DRP-16612
Feb 11, 2029
(no brand name)Dolutegravir (as sodium) + Lamivudine + Tenofovir Disoproxil (as fumarate)
50 mg/300 mg/ 300 mg Film-Coated TabletWhite opaque round HDPE containers closed white opaque polypropylene child resistant closure with induction-sealing wad.
Rx
APL Healthcare Limited, Unit-IVIndia
S.M.H.P. Marketing & Consultancy
DR-XY48976
Jan 10, 2029
(no brand name)Dolutegravir (as sodium) + Lamivudine + Tenofovir disoproxil fumarate
50 mg/300 mg/300 mg Film-Coated TabletOpaque white, round HDPE bottle with opaque white, child-resistant PP closure and one (1) silica gel sachet (as desiccant) x 30 tablets (box of 30 tablets) Opaque white, round HDPE bottle with opaque white, child-resistant PP closure and two (2) silica gel sachets (as desiccant) x 90 tablets (box of 90 tablets) Shanghai Desano
Rx
Bio-Pharmaceutical Co., Ltd.China
Biocare Lifesciences, Inc.
DRP-17651
Feb 12, 2031
(no brand name)Dolutegravir (as sodium) + Lamivudine + Tenofovir Disoproxil Fumarate
50mg/300mg/300mg Film-Coated TabletHDPE Bottle Pack of 30's with 5g silica (Box of 30 tablets) HDPE Bottle Pack of 90's with 5g silica (Box of 90 tablets) HDPE Bottle Pack of 180's with 5g silica (Box of 180 tablets)
Rx
Sun Pharmaceutical Industries LimitedIndia
Sun Pharma Philippines, Inc.
DR-XY48471
Nov 17, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .